艾伯維公司 ABBV 深 滬
已收盤 05-08 16:00:00 美东时间
201.55
-1.160
-0.57%
華盛通- 最 高202.40
- 今 開201.92
- 成交量 491.57万股
- 最 低 200.02
- 昨 收 202.71
- 總市值 3564.94亿
- 52周最高 239.71
- 市盈率 靜 85.37
- 換手率 0.28%
- 52周最低 173.51
- 委 比 0.00%
- 總股本 17.69亿
- 歷史最高 239.71
- 量 比 0.84
- 振 幅 1.17%
- 歷史最低 -20.34
- 每 手 1
- 風險率 17.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AbbVie’s New Drug Milestone Fuels Hype Despite Insider Selling
AbbVie ( ($ABBV) ) has been popular among investors this week. Here is a recap ...
05-09 23:03
全球药企研发投入TOP 15榜单揭晓！
默沙东 默沙东持续通过研发与收购扩展研发管线。今年3月，该公司斥资约67亿美元收购了Terns Pharmaceuticals，获得治疗慢性髓系白血病...
05-09 07:31
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABB...
05-08 00:30
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
Pyxis Oncology appoints Nelson Azoulay as Chief Business Officer. With over 15 years of experience in corporate strategy and biopharma transactions, Azoulay will lead corporate development and advance MICVO, the company's lead ADC targeting EDB+FN in solid tumors. MICVO is in Phase 1/2 trials for recurrent/metastatic head and neck cancer and has received FDA Fast Track Designation. Azoulay's expertise in ADCs and strategic transactions is expecte...
05-07 20:05
直播推荐 | 告别体外编辑:体内CAR-T治疗的研发进展与CMC挑战
（来源：抗衰老产业联盟） 2026年4月20日，礼来制药以70 亿美元天价收购体内CAR-T企业Kelonia Therapeutics，预付款 32.5 亿...
05-07 10:28
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Healthpeak Properties Q1 Earnings Preview
Healthpeak Properties (DOC) is scheduled to announce Q1 earnings results on Tuesday, May 5th, after market close. The consensus FFO Estimate is $0.43 and the consensus Revenue Estimate is $693.13M. Mo...
05-05 05:35
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements Changes dateline, updates paragraph 1, adds Regeneron's deal details May 4 (Reuters) - U.S. President Donald Trump secured agreements with 17 major pharmaceutical companies to bring U.S. prescription drug pric
05-04 22:45
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms Changes dateline, updates paragraph 1, adds Amgen's investment May 4 (Reuters) - Global drugmakers have been ramping up U.S. manufacturing and stockpiling inventory as the Trump administration moves to impose 100% tariffs on
05-04 21:45
